Hepatitis B: Four trials to watch over the next 12 months
The biggest unmet need for Hepatitis B patients is a cure, but there are a number of trials looking to…
hepatitis B
-
-
Arbutus previews Hepatitis B RNAi treatment data
Arbutus is gearing up to present preliminary safety and antiviral activity of AB-729 combination treatment in virally suppressed, HBeAg-negative subjects…
-
AiCuris finds chronic hepatitis B drug candidate safe in Phase I trial
German drug development company AiCuris Anti-infective Cures has reported positive results from the Phase I clinical trial of AIC649 for…
